DL-40Homo sapiens (Human)Cancer cell line

Also known as: DL40

🤖 AI SummaryBased on 4 publications

Quick Overview

T-cell lymphoma cell line for cancer research

Detailed Summary

DL-40 is a T-cell lymphoma cell line derived from an aggressive large cell lymphoma. It is characterized by a mutation in the p53 gene, specifically a T to G transition in exon 5, leading to a Cys to Phe change at codon 176. This cell line exhibits resistance to ionizing radiation-induced apoptosis, with delayed apoptotic responses compared to cell lines with wild-type p53. DL-40 has been used in studies investigating the mechanisms of radiation resistance and the role of p53 in apoptosis. Additionally, DL-40 has been utilized in research on cytokine receptor signaling and JAK/STAT pathway dependencies in anaplastic large cell lymphoma (ALCL).

Research Applications

Cancer researchApoptosis mechanismsRadiation resistanceJAK/STAT pathway studies

Key Characteristics

p53 mutation (T to G in exon 5)Resistance to ionizing radiation-induced apoptosisCytokine receptor signaling dependency
Generated on 6/19/2025

Basic Information

Database IDCVCL_2889
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age64
Age CategoryAdult
SexFemale

Disease Information

DiseaseALK-negative anaplastic large cell lymphoma
LineageLymphoid
SubtypeAnaplastic Large-Cell Lymphoma ALK Negative
OncoTree CodeALCLALKN

DepMap Information

Source TypeAcademic lab
Source IDACH-001060_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Cys176Phe (c.527G>T)Unspecified-PubMed=8221663

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
13,14
D13S317
9,13
D16S539
10,11
D5S818
9,12
D7S820
10,11
TH01
8
TPOX
8,9
vWA
14,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.

Kadin M.E., Del Mistro A., Woessner R.D., Jaffe E.S., Waldmann T.A.

Proc. Natl. Acad. Sci. U.S.A. 114:3975-3980(2017).

Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma.

Drexler H.G., MacLeod R.A.F.

Leukemia 18:1569-1571(2004).

Ionizing radiation-induced apoptosis in human lymphoma cell lines differing in p53 status.

Kariya S., Terashima M., Kubonishi I., Yoshida S.

Int. J. Mol. Med. 5:139-143(2000).

Metastatic potential of lymphoma/leukemia cell lines in SCID mice is closely related to expression of CD44.

Liu C., Kondo E., Minowada J., Akagi T.

Jpn. J. Cancer Res. 87:1070-1077(1996).

A Ki-1 (CD30)-positive T (E+, CD4+, Ia+)-cell line, DL-40, established from aggressive large cell lymphoma.

Ohyashiki K., Toyama K., Ohtsuki Y., Miyoshi I.

Cancer Res. 50:7682-7685(1990).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).